Cargando…
Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial
BACKGROUND: Approximately 10%–15% of people with diabetes develop at least one foot ulcer during their lifetime. Treatment of diabetic foot ulcers (DFUs) represents a significant economic burden. Enzymatic debridement with clostridial collagenase ointment (CCO) can be used to remove necrotic tissue...
Autores principales: | Motley, Travis A, Gilligan, Adrienne M, Lange, Darrell L, Waycaster, Curtis R, Dickerson, Jaime E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357050/ https://www.ncbi.nlm.nih.gov/pubmed/25767565 http://dx.doi.org/10.1186/s13047-015-0065-x |
Ejemplares similares
-
Erratum to: Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial
por: Motley, Travis A., et al.
Publicado: (2016) -
Clinical Outcomes for Diabetic Foot Ulcers Treated with Clostridial Collagenase Ointment or with a Product Containing Silver
por: Motley, Travis A., et al.
Publicado: (2018) -
Comparative Effectiveness of Clostridial Collagenase Ointment to Medicinal Honey for Treatment of Pressure Ulcers
por: Gilligan, Adrienne M., et al.
Publicado: (2017) -
Economic analysis and budget impact of clostridial collagenase ointment compared with medicinal honey for treatment of pressure ulcers in the US
por: Mearns, Elizabeth S, et al.
Publicado: (2017) -
Difficult-to-heal wounds of mixed arterial/venous and venous etiology: a cost-effectiveness analysis of extracellular matrix
por: Romanelli, Marco, et al.
Publicado: (2016)